Dr Seddon Reed Savage, MD in New Canaan, CT - Pain Medicine

Dr Seddon Reed Savage, MD is a Pain Medicine - Pain Medicine physician based in New Canaan, Connecticut. Dr Seddon Reed Savage is licensed to practice in New Hampshire (license number 7219) and her current practice location is 208 Valley Rd, New Canaan, Connecticut. She can be reached at her office (for appointments etc.) via phone at (203) 801-2224.

NPI number for Dr Seddon Reed Savage is 1336226745 and her current mailing address is 6 Auburn St, Concord, New Hampshire. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1336226745.

Contact Information

	Dr Seddon Reed Savage, MD
	208 Valley Rd, New Canaan, CT 06840-3812
	(203) 801-2224
	Not Available

Physician's Profile

Full Name	Dr Seddon Reed Savage
Gender	Female
Speciality	Pain Medicine - Pain Medicine
Location	208 Valley Rd, New Canaan, Connecticut
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1336226745
Provider Enumeration Date: 11/01/2006
Last Update Date: 01/27/2012

Medical Identifiers

Medical identifiers for Dr Seddon Reed Savage such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1336226745	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	7219 (New Hampshire)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Seddon Reed Savage is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Seddon Reed Savage, MD 6 Auburn St, Concord, NH 03301-3001 Ph: (603) 491-6104	Dr Seddon Reed Savage, MD 208 Valley Rd, New Canaan, CT 06840-3812 Ph: (203) 801-2224

News Archive

Joint report calls for action on child nutrition in countries with highest numbers of malnourished children

"Countries with the highest numbers of malnourished children urgently need to step up the way they respond to the problem in order to prevent millions of unnecessary deaths, according to a joint report," titled the "Nutrition Barometer" and released on Friday by Save the Children and World Vision, AlertNet reports.

Senator discusses small business amendments in health bill

United States Senate Committee on Small Business and Entrepreneurship Chair, Mary L. Landrieu, D-La., yesterday spoke on the Senate floor about the significant small business reforms within the Senate health bill that would provide entrepreneurs with more choices and stable costs.

Leading allergy organizations release report that sheds light on angioedema

With today's modern medicine, misdiagnoses may be unexpected and surprising. But when symptoms of an unknown and uncommon illness mimic a number of other conditions, it can be difficult for medical professionals to properly diagnose and treat patients. That's why four leading allergy/immunology organizations have announced the release of a report to help set a new standard for a commonly misdiagnosed, under-recognized and under treated condition known as angioedema, the rapid swelling of deep layers of skin and tissue.

Researchers study how skin stem cells respond to forces

All cells share the same genetic code, no matter if they are skin or brain cells. However, these cells are exposed to very different types of mechanical environments and mechanical stresses.

NIH approves $6.6 million in funding for Phase 2a adult eradication study of Argos' AGS-004

Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on the Arcelis technology platform, today announced that the NIH Division of AIDS (DAIDS) has approved $6.6 million in funding for an investigator-initiated Phase 2a adult eradication study of AGS-004, the company's investigational fully personalized immunotherapy for HIV.

Dr Seddon Reed Savage, MD - Pain Medicine in New Canaan, CT